CTLA4 and melanoma: Among them, MIR205HG expression is associated with the poor outcome of patient and its expression is positively correlated with the expressions of immune checkpoints like PD-1, CTLA4, LAG3, and TIM3 in adenocarcinoma and melanoma (51).